<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">BUTENAFINE HYDROCHLORIDE</span><br/>(bu-ten'a-feen)<br/><span class="topboxtradename">Mentax<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antifungal antibiotic</span><br/><b>Prototype: </b>Terbinafine<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1% cream</p>
<h1><a name="action">Actions</a></h1>
<p>Exerts antifungal action by inhibiting sterol synthesis, which may enhance susceptibility of the fungal membrane to damage
         by butenafine.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Antifungal effectiveness against interdigital <i>tinea pedis</i> (athlete's foot), <i>tinea corporis</i> (ringworm), and <i>tinea cruris</i> (jock itch).
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of tinea pedis, tinea corporis, and tinea cruris due to <i>Epidermophyton floccosum, Trichophyton mentagrophytes, Trichophyton rubrum.</i>
</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to butenafine.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Hypersensitivity to naftifine or tolnaftate; pregnancy (category B); lactation. Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Tinea Pedis</span><br/><span class="rdage">Adult/Child:</span> <span class="rdroute">Topical</span> &gt;<i>12 y,</i> Apply to affected area and surrounding skin b.i.d. times 7 d or q.d. times 4 wk<br/><br/><span class="indicationtitle">Tinea Corporis, Tinea Cruris</span><br/><span class="rdage">Adult/Child:</span> <span class="rdroute">Topical</span> &gt;<i>12 y,</i> Apply to affected area and surrounding skin once daily<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Apply sufficient cream to cover affected skin and surrounding areas.</li>
<li>Do not use occlusive dressing unless specifically directed to do so.</li>
<li>Store at 5°30° C (41°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Skin:</span> Burning/stinging at application site, contact dermatitis, erythema, irritation, itching. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>
            							Note: 24 wk of therapy are usually required for effective treatment.
            						
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Discontinue medication and notify physician if irritation or sensitivity develops.</li>
<li>Avoid contact with mucous membranes.</li>
<li>Wash hands thoroughly before and after application of cream.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>